Hexagon
Hexagon62About
What does Hexagon do?
Hexagon Bio is a biopharmaceutical company that leverages a proprietary interdisciplinary platform combining machine learning, genomics, synthetic biology, and automation. They mine microbial genomes to discover and develop structurally diverse small-molecule therapeutics for oncology and infectious diseases.
What is Hexagon's revenue?
StartupHub estimates Hexagon's annual revenue at $17.1M (range $11.9M to $31.0M, 67% confidence), based on comparable companies in the sector.
What is Hexagon's valuation?
StartupHub estimates Hexagon's effective valuation at $95.4M (range $40.5M to $168.5M, 47% confidence), based on comparable companies in the sector.
How much funding has Hexagon raised?
Hexagon has raised a total of $61M in funding. The most recent round on record is Series A.
Where is Hexagon headquartered?
Hexagon is headquartered in Menlo Park, United States.
When was Hexagon founded?
Hexagon was founded in 2017.
What industry does Hexagon operate in?
Hexagon operates in AI, Biotech, Drug Discovery.
How many employees does Hexagon have?
Hexagon has approximately 67 people on record.
No comments yet. Be the first to share your take.